ZFIN ID: ZDB-PUB-180404-5
Transient fibrosis resolves via fibroblast inactivation in the regenerating zebrafish heart
Sánchez-Iranzo, H., Galardi-Castilla, M., Sanz-Morejón, A., González-Rosa, J.M., Costa, R., Ernst, A., Sainz de Aja, J., Langa, X., Mercader, N.
Date: 2018
Source: Proceedings of the National Academy of Sciences of the United States of America   115(16): 4188-4193 (Journal)
Registered Authors: Gonzalez-Rosa, Juan Manuel, Mercader Huber, Nadia, Sánchez Iranzo, Héctor
Keywords: cardiomyocyte proliferation, fibroblast inactivation, fibrosis, heart regeneration, zebrafish
Microarrays: GEO:GSE101199, GEO:GSE101200, GEO:GSE101204
MeSH Terms:
  • Animals
  • Animals, Genetically Modified
  • Base Sequence
  • Cell Adhesion Molecules/biosynthesis
  • Cell Lineage
  • Cold Temperature/adverse effects
  • Collagen Type XII/biosynthesis
  • Collagen Type XII/genetics
  • Endocardium/pathology
  • Extracellular Matrix/metabolism
  • Fibroblasts/physiology*
  • Fibrosis
  • Gene Expression Regulation
  • Genes, Reporter
  • Heart/physiology*
  • Heart Injuries/genetics
  • Heart Injuries/physiopathology
  • Myocardium/pathology
  • Myocytes, Cardiac/metabolism
  • Myocytes, Cardiac/pathology
  • RNA, Messenger/biosynthesis
  • Regeneration/physiology*
  • Transcriptome
  • Zebrafish
  • Zebrafish Proteins/biosynthesis
  • Zebrafish Proteins/genetics
PubMed: 29610343 Full text @ Proc. Natl. Acad. Sci. USA
In the zebrafish (Danio rerio), regeneration and fibrosis after cardiac injury are not mutually exclusive responses. Upon cardiac cryoinjury, collagen and other extracellular matrix (ECM) proteins accumulate at the injury site. However, in contrast to the situation in mammals, fibrosis is transient in zebrafish and its regression is concomitant with regrowth of the myocardial wall. Little is known about the cells producing this fibrotic tissue or how it resolves. Using novel genetic tools to mark periostin b- and collagen 1alpha2 (col1a2)-expressing cells in combination with transcriptome analysis, we explored the sources of activated fibroblasts and traced their fate. We describe that during fibrosis regression, fibroblasts are not fully eliminated but become inactivated. Unexpectedly, limiting the fibrotic response by genetic ablation of col1a2-expressing cells impaired cardiomyocyte proliferation. We conclude that ECM-producing cells are key players in the regenerative process and suggest that antifibrotic therapies might be less efficient than strategies targeting fibroblast inactivation.